Status: Recruiting
Mesenchymal Stem Cells Treatment for AIDS Patients at Late Stage
The goal of this study is to conduct a prospective, double-blind, randomized placebo-controlled clinical trial to investigate the safety and efficacy of mesenchymal stem cells treatment for AIDS patients at late stage.
Participants needed: 150
Trial details
Phase: Phase 1, Phase 2Age: 18-65Biological sex: AllType: InterventionalSponsor: Cell Energy Life Sciences Group Co. LTDUpdated: Aug 12, 2025Locations: 4
Eligibility criteria
Confirmed HIV infection, aged 18-65, both genders [+2]
have HBV/HCV/HDV/HEV infection, and the virological test is positive. [+12]